Answers are grounded in this paper and cite their sources.
= 68); CEUS helped appropriately categorize both LR-5 and LR-M lesions as HCC and non-HCC malignancies, respectively, and resulted in management recommendation changes in 40% (27 of 68) of observations with 100% accuracy. Conclusion CEUS resolved some high-risk indeterminate liver observations (categorized as LR-4 and LR-M at CT or MRI), with particularly high clinical impact for observations measuring at least 20 mm. Clinical trial registration no.
No takes yet. Share an insight, caveat, or question.
Lyshchik et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: